DCTH

Delcath Systems Inc.

Price

$16.37

return (12m)

50.18%

p/e

1,101.74

p/bv

4.82

DIVIDEND YIELD

0.00%

DCTH price

Delcath Systems

If you had invested

exposure

years ago

ago, you would now have *

ago, you would now have:

*This calculation reflects price variation only.

Return on Investment DCTH

1 month

3 months

1 year

2 years

5 years

10 years

return

1 month

27.59%

3 months

53.42%

1 year

50.18%

2 years

55.02%

5 years

57.71%

10 years

-100.00%

Asset Comparator

If you had invested

years ago

ago, you would now have *

ago, you would now have:

*This calculation reflects price variation only.

Fundamentals DCTH

Valuation

P/E

1,101.74

Sector -0.30

Industry -3.74

P/BV

4.82

Sector 1.88

Industry 1.32

P/Revenue (PSR)

6.12

Sector 1.62

Industry 2.27

EV/EBITDA

Sector -56.73

Industry -38.51

EV/EBIT

Sector -495.32

Industry -61.92

P/EBITDA

Sector -192.31

Industry -39.83

P/EBIT

Sector -230.06

Industry -59.07

P/Total Assets

4.26

Sector 0.90

Industry 0.86

P/Net Current Assets

5.09

Sector -24.09

Industry -82.44

P/Working Capital

4.98

Sector -5.12

Industry -6.69

EPS

0.01

Sector -0.78

Industry -1.25

BVPS

3.37

Sector 3.80

Industry 2.23

Efficiency

Gross Margin

87.07%

Sector 48.34%

Industry 49.22%

EBITDA Margin

0.00%

Sector -5,407,515.68%

Industry -20,100,387.98%

EBIT Margin

0.00%

Sector -62.93%

Industry -18,749,058.89%

Operating Margin

-1.90%

Sector -22.73%

Industry -30.01%

Net Profit Margins

0.56%

Sector -27.03%

Industry -32.63%

Asset Turnover

0.21

Sector 0.13

Industry 0.06

Profitability

ROE

0.44%

Sector -30.72%

Industry -44.11%

ROA

0.39%

Sector -28.03%

Industry -50.97%

ROIC

0.00%

Sector -317.33%

Industry -162.60%

Dividends

Dividend yield

0.00%

Sector -

Industry -

Payout

0.00%

Sector -

Industry -

Debt

Current Ratio

9.83

Sector 1.85

Industry 2.38

Net Debt / EBITDA

Sector -42.45

Industry -15.77

Net Debt / EBIT

Sector -37.26

Industry -71.89

Net Debt / Equity

0.00

Sector -1.04

Industry -1.11

Gross Debt / Equity

0.00

Sector -0.72

Industry -0.54

Equity/Assets

0.88

Sector 0.44

Industry 0.49

Liabilities/Assets

0.12

Sector 0.48

Industry 0.44

Growth

5Y Revenue CAGR

93.03%

Sector -

Industry -

5Y Earnings CAGR

0.00%

Sector -

Industry -

Fundamentals DCTH

DRAG THE FRAME TO SEE MORE DATA

FAIR VALUE OF Delcath Systems ACCORDING TO BENJAMIN GRAHAM

Graham's Fair Value

The Fair Value formula was created by Benjamin Graham to identify stocks with appreciation potential or that are being traded for less than they are worth. Graham was one of the greatest investors in history and Warren Buffett’s mentor.

Current price

$16.37

Fair Value

$0.87

Upside Return potential.

-94.68%

See Graham's ranking

Because it considers equity value in its calculation, this formula may not work well for technology companies.

This is not a buy/sell recommendation; the fair value calculation takes into account only the formula created by Benjamin Graham, published in the book The Intelligent Investor.

Assets	Price (US$)	Return 12m	DY	P/E	P/BV	ROE	Net Profit Margins
DCTH Delcath Systems Inc.	$16.37	50.18%	0.00%	1,101.74	4.82	0.44%	0.56%
ISRG Intuitive Surgical Inc.	$368.37	-21.47%	0.00%	41.68	7.19	17.26%	28.62%
ABT Abbott Laboratories	$108.56	-15.99%	2.25%	35.46	3.76	10.61%	11.65%
MDT Medtronic PLC	$92.44	3.06%	3.15%	24.14	2.31	9.59%	13.20%
BSX Boston Scientific Corp.	$47.00	-55.93%	0.00%	16.90	0.00	-%	19.57%
TMDX TransMedics Group Inc.	$86.32	-22.62%	0.00%	21.17	6.20	29.28%	22.69%
IDXX IDEXX Laboratories Inc.	$530.26	-17.08%	0.00%	38.35	27.10	70.67%	25.03%
RMD ResMed Inc.	$229.58	-14.20%	1.01%	22.70	5.31	23.41%	27.44%
COHR Coherent Inc.	$267.30	204.44%	0.00%	118.60	4.87	4.11%	6.85%
SYK Stryker Corp.	$309.96	-19.49%	1.07%	33.63	5.23	15.55%	14.43%
PHG Koninklijke Philips NV	$25.99	-0.19%	3.79%	19.71	1.93	9.80%	6.30%
INMD InMode Ltd.	$14.83	2.91%	0.00%	11.29	1.39	12.32%	20.69%
DXCM DexCom Inc.	$89.56	20.54%	0.00%	34.58	13.19	38.14%	20.12%
EW Edwards Lifesciences Corp.	$89.61	9.59%	0.00%	51.78	4.85	9.36%	15.41%
BDX Becton Dickinson and Company	$186.97	2.37%	2.23%	54.97	2.12	3.86%	6.30%
ALGN Align Technology Inc.	$158.41	15.49%	0.00%	27.43	2.68	9.77%	9.99%
IRMD iRadimed Corporation	$86.37	21.97%	1.45%	49.47	11.21	22.66%	26.71%
SNN Smith & Nephew PLC	$28.65	-19.72%	2.69%	10.82	2.35	21.74%	9.20%

Stock vs Indice Comparison Tool

If you had invested

years ago

ago, you would now have *

ago, you would now have:

*This calculation reflects price variation only.

DCTH Historical Dividends

current DY: 0.00%

5-year average DY: 0.00%

no dividend paid in the period.

ABOUT Delcath Systems

Delcath Systems Inc.

Average Investor10 user rating

4.0 (1 people)

United States

38 years

Founded: 1988

2000

Time since IPO - 26 years

36

Employees

Delcath Systems Inc. (United States) is listed on the Nasdaq and has a market capitalization of $583.92 million, with shareholders equity totaling $121.14 million.

The company employs approximately 36 people and operates in the Health sector, within the Medical Supplies and Equipment industry.

Over the past 12 months, Delcath Systems Inc. reported $95.41 million in revenue, generating net income of $530.00 Thousand.

Key financial metrics include a P/E ratio of 1,101.74, a price-to-book (P/B) ratio of 4.82, and a trailing twelve-month dividend yield of 0.00%.

The company trades under the ticker DCTH.

Market cap

$583.92 million

Net worth

$121.14 million

$121,140,000.00

Assets

$137.02 million

$137,020,000.00

Total Shares Outstanding

36.00 million

36,000,000

Average Daily Trading Volume

$553.98 Thousand

$553,976.00

Sector

Health

Industry

Medical Supplies and Equipment

DCTH

DCTH revenue and profits

Financial Results DCTH

DRAG THE FRAME TO SEE MORE DATA

DCTH cash flow

DRAG THE FRAME TO SEE MORE DATA

Discover more assets

CVS - CVS Health

$97.84 37,65% (12M)

P/E

-0.84

2.84%

ROE

-178.93%

P/BV

1.50

CI - Cigna

$284.92 --2,55% (12M)

P/E

10.72

2.21%

ROE

16.04%

P/BV

1.72

CNC - Centene

$68.28 127,15% (12M)

P/E

-6.23

0.00%

ROE

-22.56%

P/BV

1.40

HUM - Humana

$412.33 34,08% (12M)

P/E

36.19

0.91%

ROE

6.72%

P/BV

2.43

SNY - Sanofi

$44.30 --7,70% (12M)

P/E

7.29

3.94%

ROE

18.43%

P/BV

1.34

LLY - Eli Lilly

$1,154.74 60,15% (12M)

P/E

39.01

0.55%

ROE

P/BV

HCA - HCA Healthcare

$409.57 1,14% (12M)

P/E

11.79

0.72%

ROE

-244.72%

P/BV

-28.86

NVS - Novartis

$162.77 29,40% (12M)

P/E

27.32

2.03%

ROE

27.47%

P/BV

7.50